2,4,6-三羟基苯基-4'-羟基苄基甲酮 | 15485-65-1

• 物质功能分类: 医药中间体 - 原料药中间体
• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 中文名称: 2,4,6-三羟基苯基-4'-羟基苄基甲酮
• 中文别名: Α-(4'-羟基苯基)-2,4,6-三羟基苯乙酮
• 英文名称: 2,4,4',6-tetrahydroxydeoxybenzoin
• 英文别名: 1-(2,4,6-trihydroxyphenyl)-2-(4-hydroxyphenyl)ethanone；2,4,6-trihydroxy-α-p-hydroxyphenylacetophenone；2-(4-Hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)ethanone
• CAS: 15485-65-1
• 化学式: C₁₄H₁₂O₅
• 分子量: 260.246
• InChiKey: XYMPPRJBUSAOQA-UHFFFAOYSA-N

物化性质

• 熔点：
  240-245°C (dec.)
• 沸点：
  509.4±19.0 °C(Predicted)
• 密度：
  1.483±0.06 g/cm3 (20 ºC 760 Torr)
• 溶解度：
  可溶于丙酮、DMSO（少量）、甲醇（少量）

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  98
• 氢给体数：
  4
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2,4,6-三羟基苯基-4'-羟基苄基甲酮 在 三氟化硼乙醚 、 甲基磺酰氯 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 12.0h， 以90%的产率得到染料木素
  参考文献：
  名称：

  两种生物活性异黄酮糖苷Talosin A和B的合成

  摘要：

  Talosin A和B，即染料木素7‐ O ‐ α ‐ L ‐6‐脱氧塔洛吡喃糖苷和染料木素4′，7‐di‐ O ‐ α ‐ L ‐‐6‐脱氧塔洛吡喃糖苷，显示出优异的抗真菌和抗炎活性，简明扼要。

  DOI：

  10.1002/cjoc.201090291
• 作为产物：
  描述：

  染料木素 在 sodium hydroxide 作用下， 以65%的产率得到2,4,6-三羟基苯基-4'-羟基苄基甲酮
  参考文献：
  名称：

  Synthesis, crystal structure and antimicrobial activity of deoxybenzoin derivatives from genistein

  摘要：

  A series of deoxybenzoin derivatives from genistein were synthesized and their structures were elucidated by H-1 NMR, mass spectral data and micro analyses. The structures of 2, 7 and 10 were determined by single-crystal X-ray analysis. These obtained compounds were evaluated for their assayed antibacterial (Bacillus subtilis, Escherichia coli, Pseudomonas fluorescence and Staphylococcus aureus) and antifungal (Aspergillus niger, Candida albicans and Trichophyton rubrum) activities by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium. bromide) method. Most compounds have displayed comparable antibacterial activity against bacterial. On the basis of the biological results, structure-activity relationships are discussed. (c) 2007 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2007.05.013

文献信息

• [EN] ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS ANTI-VIRAUX, COMPOSITIONS PHARMACEUTIQUES ET MÉTHODES D'UTILISATION DE CES DERNIERS
  申请人：KINETA INC

  公开号：WO2016073947A1

  公开（公告）日：2016-05-12

  Disclosed herein are compounds and pharmaceutical compositions, and uses thereof for the treatment of viral infections, including RNA viral infections. The compounds, pharmaceutical compositions, and methods disclosed herein can relate to chromenone drug candidate compounds that modulate innate immunity along the RLR-IRF3 axis. These compounds activate innate immune signaling downstream of numerous viral countermeasures and are a unique addition to conventional antiviral compounds in development or on the market. These compounds possess broad spectrum in vitro activity against diverse RNA viruses including the respiratory pathogens influenza, RSV, and hCoV, with EC50 values in the low nanomolar range. Potent in vitro activity is also demonstrated against systemic and emerging viruses including Dengue and Ebola.

  披露了用于治疗病毒感染，包括RNA病毒感染的化合物和药物组合物及其用途。所披露的化合物、药物组合物和方法可能与调节RLR-IRF3轴上先天免疫的色酮类药物候选化合物相关。这些化合物激活了针对多种病毒对策的先天免疫信号传导，并且是对开发中或市场上的传统抗病毒化合物的独特补充。这些化合物在试管中对包括呼吸道病原体流感、呼吸道合胞病毒和人类冠状病毒在内的多种RNA病毒具有广泛的谱系活性，EC50值在低纳摩尔范围内。还展示了针对系统和新兴病毒（包括登革热和埃博拉）的强大试管内活性。
• Arylalkyl Ketones, Benzophenones, Desoxybenzoins and Chalcones Inhibit TNF-α Induced Expression of ICAM-1: Structure-Activity Analysis
  作者：Sarvesh Kumar、Chandra Shekhar Reddy L、Yogesh Kumar、Amit Kumar、Brajendra K. Singh、Vineet Kumar、Shashwat Malhotra、Mukesh K. Pandey、Rajni Jain、Rajesh Thimmulappa、Sunil K. Sharma、Ashok K. Prasad、Shyam Biswal、Erik Van der Eycken、Anthony L. DePass、Sanjay V. Malhotra、Balaram Ghosh、Virinder S. Parmar

  DOI：10.1002/ardp.201100279

  日期：2012.5

  potent intercellular cell adhesion molecule‐1 (ICAM‐1) inhibitors, a large number of arylalkyl ketones, benzophenones, desoxybenzoins and chalcones and their analogs (54 in total) have been synthesized and screened for their ICAM‐1 inhibitory activity. The structure‐activity relationship studies of these compounds identified three potent chalcone derivatives and also demonstrated the possible mechanism

  白细胞和血管内皮细胞 (EC) 之间通过细胞粘附分子的相互作用在各种炎症和自身免疫性疾病的发病机制中起着重要作用。阻断这些相互作用的小分子已成为针对急性和慢性炎症疾病的潜在治疗剂。为了鉴定有效的细胞间细胞粘附分子-1 (ICAM-1) 抑制剂，已经合成了大量的芳烷基酮、二苯甲酮、脱氧安息香和查耳酮及其类似物（共 54 种），并筛选了它们的 ICAM-1 抑制剂活动。这些化合物的构效关系研究确定了三种有效的查耳酮衍生物，并证明了其 ICAM-1 抑制活性的可能机制。
• 7-Hydroxy-benzopyran-4-one Derivatives: A Novel Pharmacophore of Peroxisome Proliferator-Activated Receptor α and -γ (PPARα and γ) Dual Agonists
  作者：Azadeh Matin、Navnath Gavande、Moon S. Kim、Nancy X. Yang、Noeris K. Salam、Jane R. Hanrahan、Rebecca H. Roubin、David E. Hibbs

  DOI：10.1021/jm900964r

  日期：2009.11.12

  Design, synthesis, and in vitro bioevaluation of a new class of potential dual PPARα and γ agonists discovered through a structure-driven design paradigm are described. The 7-hydroxy-benzopyran-4-one moiety (includes flavones, flavanones, and isoflavones) is the key pharmacophore of these novel molecules, exhibiting similarity to the core structure of both fibrates and thiazolidinediones. New lead

  描述了通过结构驱动设计范式发现的新型潜在的双重PPARα和γ双重激动剂的设计，合成和体外生物评价。7-羟基-苯并吡喃-4-酮部分（包括黄酮，黄烷酮和异黄酮）是这些新分子的关键药效​​基团，与贝特类药物和噻唑烷二酮的核心结构相似。从“保健食品”和合成类似物中鉴定出新的PPAR配体。总共筛选了77个分子，包括查耳酮，黄酮，黄烷酮，异黄酮和吡唑衍生物，并进行了双重激动剂的构效关系研究。化合物68，70，72，和76被鉴定为新型有效的PPARα和γ双重激动剂。这些新型分子可能会成为PPAR相关疾病（包括II型糖尿病和代谢综合征）未来的领先者。
• An Expedient Synthesis of 2-(ω-Carboxyalkyl)polyhydroxyisoflavones
  作者：Nawaf Al-Maharik、Ilpo Mutikainen、Kristiina Wähälä

  DOI：10.1055/s-2000-6351

  日期：——

  Derivatives of the isoflavones daidzein and genistein, carrying a carboxyalkyl attachment at C-2 were prepared by cyclization of unprotected 2,4,4′-trihydroxy- or 2,4,4′,6-tetrahydroxydeoxybenzoin in the presence of a number of 1,ω-alkanedicarboxylic acid monoester monochlorides, K2CO3 and a phase-transfer catalyst in dry acetone. Hydrolysis under basic conditions of the resulting 2-(ω-alkoxycarbonylalkyl)isoflavones gives the title compounds, useful for developing RIA techniques for the analysis of the parent isoflavones.

  将雌激素大豆黄素和大豆黄苷的衍生物，即在C-2位上带有羧基烷基的大豆黄素和大豆黄苷的制备方法，是通过将未保护的2,4,4'-三羟基或2,4,4',6-四羟基脱氧苯甲酸在含有一系列1,ω-烷二羧酸单酯单氯化物、碳酸钾和相转移催化剂的干燥丙酮中进行环化得到的。在碱性条件下对所得的2-(ω-烷氧羰基烷基)异黄酮进行水解，得到标题化合物，这些化合物对于开发用于分析母体异黄酮的RIA技术非常有用。
• A Direct Synthesis of 2‐(ω‐Carboxyalkyl)isoflavones from <i>ortho</i> ‐Hydroxylated Deoxybenzoins
  作者：Galyna P. Mrug、Bohdan A. Demydchuk、Svitlana P. Bondarenko、Vitaliy M. Sviripa、Przemyslaw Wyrebek、James L. Mohler、Michael V. Fiandalo、Chunming Liu、Mykhaylo S. Frasinyuk、David S. Watt

  DOI：10.1002/ejoc.201801171

  日期：2018.10.24

  The base‐catalyzed chromone ring‐closure reaction was developed for one‐step synthesis of various 2‐(ω‐carboxyalkyl)isoflavones bearing electron‐donating and electron‐withdrawing groups.

  开发了碱催化的色酮闭环反应，用于一步合成具有供电子基团和吸电子基团的各种2-（ω-羧基烷基）异黄酮。